Individual Health vs. Public Health If you’re the 1/1000, it’s a 100% for you What absolute level of risk will society/an individual tolerate? Population-based.

Slides:

Advertisements

Similar presentations

PERSONALIZED MEDICINE: Planning for the Future You, Your Biomarkers and Your Rights.

Advertisements

CANCER SCREENING 2011 DELAWARE CANCER EDUCATION ALLIANCE STEPHEN S. GRUBBS, M.D. HELEN F. GRAHAM CANCER CENTER DELAWARE CANCER CONSORTIUM OCTOBER 5, 2011.

Colorectal Cancer Screening and Surveillance FDA Advisory Committee March, 2002 David Lieberman MD Chief, Division of Gastroenterology Oregon Health Sciences.

Spotlight on Colorectal Cancer Screening 1 1. Home Screening for Colon Cancer

All Payer Claims Database APCD Databases created by state mandate, that includes data derived from medical, eligibility, provider, pharmacy and /or dental.

Update on Screening of Gastrointestinal Diseases Niraj Jani, M.D. Greater Baltimore Medical Center 1/30/15.

Screening for Colorectal Cancer Cancer Symposium: Measuring the Benefits of Screening and Treatment October 2007.

Understanding Those Who Do and Do Not Plan to Get Colorectal Cancer (CRC) Screening Costanza ME, White MJ, Stark JR, Stoddard AM, Avrunin JS, Luckmann.

CONTACT INFORMATION Visit our website – To request any additional information on the PCMH or the Patient Centered Primary Care Collaborative.

CCG assurance & development

DR Jameel Tariq Miro.  Lifetime incidence 5%  90% of cases occur after age 50  One-third of patients with colorectal cancer die from the disease 

Presentation by Bill Barcellona Sr. V. P

Colorectal Cancer Paula M. Rechner M.D. War Memorial Hospital October 13, 2005.

Colorectal cancer: How do we approach health disparities? Marta L. Davila, MD, FASGE University of Texas MD Anderson Cancer Center.

Colorectal Cancer Screening John Pelzel MD Sleepy Eye Medical Center.

Haley Hyde Jessica Fordham Jena Hamm  Colorectal cancer is a leading cause of cancer related deaths every year.  150,000 Americans will be diagnosed.

Clinical Practice Screening for Colorectal Cancer David A. Lieberman, M.D. N Engl J Med Volume 361(12): September 17, 2009.

Update on Colon Cancer Screening and Prevention

A Call to Action: Prevention and Early Detection of Colorectal Cancer (CRC)

An Overview of the Alberta Screening & Prevention Initiative.

Developing a commitment to the care of people with dementia in general hospitals Outcomes of RCN project Making Sense: working in partnership to improve.

1 The Chemoprevention of Sporadic Colorectal Cancer Issues Surrounding a Benefit/Risk Analysis in Clinical Trials Mark Avigan MD CM Medical Officer Division.

Turning Data into Action for Colorectal Cancer November 17, 2014 Jessica Shaffer, Director, Maine CDC Colorectal Cancer Control Program

Assessment of Colon & Prostate Cancer Screening in WA Peggy Hannon, PhD, MPH Alliance for Reducing Cancer NW.

Azara Proprietary & Confidential Overview June 2014 Improving Patient Outcomes through Data.

Leadership and Management Training for physicians Maria V. Gibson, MD, PhD Trident / MUSC Family Medicine Residency Program Background Practice Problem.

Implementation of an evidence-based cancer screening program for an urban disabled population Ryan Goetz BSCh Lewis Cancer & Research Pavilion at St. Joseph’s/

AIMGP Seminar Series January 2004 Joo-Meng Soh Edited by Gloria Rambaldini CANCER SCREENING PART II.

High risk population in GI field how we can find them? Ahmad Shavakhi MD Associate professor of gastroenterology.

D EPARTMENT of F AMILY M EDICINE CRC Screening: Projects in Department of Family Medicine, University of Iowa Barcey T. Levy, PhD, MD Cancer Summit October.

Decision Analysis of Colorectal Cancer Screening Tests by Age to Begin, Age to End, and Screening Intervals: Report to the United States Preventive Services.

COLORECTAL CANCER SCREENING in December of 2002 Jeffrey W. Frank, MD.

© Copyright Annals of Internal Medicine, 2014 Ann Int Med. 160 (5): ITC5-1. * For Best Viewing: Open in Slide Show Mode Click on icon or From the View.

CURRENT NATIONAL PREVENTIVE HEALTH CARE GUIDELINES Juanita Halls, M.D. Professor of Medicine General Internal Medicine University of Wisconsin - UW Health.

Our Vision – Healthy Kansans Living in Safe and Sustainable Environments.

Gender differences in colorectal cancer screening, attitudes and information preferences Joan M. Griffin, PhD Greta Friedemann-Sánchez, PhD Diana Burgess,

Slides last updated: June 2015 CRC: CLINICAL FEATURES.

“We are a compassionate team of healthcare professionals providing excellent personal care to Central Minnesota.”

Colorectal Cancer (CRC) Surveillance: Introduction and Overview Carrie Klabunde, Ph.D. IBSN Biennial Meeting Ottawa, Canada May 11-12, 2006.

American Public Health Association

1 Colorectal Cancer # 2 Cancer Killer # 2 Cancer Killer SCREENING SAVES LIVES.

An Evidence Based Approach to Colorectal Cancer Screening J. C. Ryan, M.D. Associate Professor of Medicine UCSF and SF VAMC 9/22/2014.

Barium Enema in the detection of Colon Cancer

1 Colorectal Cancer # 2 Cancer Killer # 2 Cancer Killer SCREENING SAVES LIVES.

2003: Improvements and Other Changes Francois de Brantes May, 2003 Founded by The Business Roundtable Supported by the Robert Wood Johnson Foundation.

Module 2: Quality and Quality Measures The degree to which health services for individuals and populations increase the likelihood of desired health outcomes.

Increasing Colorectal Cancer Screening through an Academic Detailing Intervention ACCN Research Roundtable October 8, 2008 Mark Dignan, Nancy Schoenberg,

Medical Homes For Children in Foster Care: A Proposal for CCNC Consideration Proposal collaboratively developed by: NC Pediatric Society Foundation & Benchmarks.

Evaluation Tools and Models Northern Plains CCC Program Comprehensive Cancer Control 2008 Annual Grantee Meetings May 14th, 2008 Atlanta, GA.

Colorectal Cancer Screening: Role of the Primary Care Provider Michael Pignone, MD, MPH University of North Carolina.

Robert E. Schoen, MD MPH Associate Professor of Medicine and Epidemiology Division of Gastroenterology University of Pittsburgh Organizing Colorectal Cancer.

Screening for Colorectal Cancer (CRC) Nov, 2007 A Aljebreen, FRCPC Division of Gastroenterology KKUH, Riyadh.

Assessing Colorectal Cancer Screening in Appalachia PA William Curry, MD, MS Mark Dignan, PhD Gene Lengerich, VMD Alan Adelman, MD, MS.

Colorectal Cancer Screening Colorectal Cancer Screening VT SGNA Conference VT SGNA Conference October 24, 2015 October 24, 2015 Lynn Butterly, MD Lynn.

Colonic cancer screening in high risk groups

The Usual Source of Care and Delivery of Preventive Services to Medicare Beneficiaries Academy Health, June 2005 Hoangmai Pham, MD, MPH Deborah Schrag,

Colorado Colorectal Screening Program Holly Wolf University of Colorado School of Medicine

Component 1: Introduction to Health Care and Public Health in the U.S. 1.9: Unit 9: The evolution and reform of healthcare in the US 1.9c: Quality Indicators.

D EPARTMENT of F AMILY M EDICINE Colorectal Cancer Screening: Update on Guidelines and Projects Barcey T. Levy, PhD, MD Professor, Department of Family.

Robert E. Schoen, MD MPH Associate Professor of Medicine and Epidemiology Division of Gastroenterology University of Pittsburgh Hereditary Colorectal Cancer:

Colorectal Cancer Screening Guidelines

A Quality improvement initiative

Michael T. Quinn, PhD University of Chicago Department of Medicine

The Effect of Key Organizational Attributes on Cancer Screening Rates

Hereditary Colorectal Cancer: From Genetic Testing to Prevention

Illustrative Health Reform Goals and Tracking Performance

Swati G. Patel, Dennis J. Ahnen

Primary and acute care to reduce morbidity and pain

Presentation transcript:

Individual Health vs. Public Health If you’re the 1/1000, it’s a 100% for you What absolute level of risk will society/an individual tolerate? Population-based approach should account for safety, cost, availability

Medicare Average Risk FOBT Annually Flex Sig q 4 yrs  Screening Colonoscopy q 10 yrs High Risk 1st degree relative w/adenoma or CA FAP, HNPCC Personal hx adenoma or CA or IBD Colonoscopy q 2 yrs Uncertainty in age group

Prevalence of FOBT/Sigmoidoscopy AGE  50 FOBT - 1 YearFS/Procto - 5 Years TotalMFTotalMF Behavioral Risk Factor Surveillance System Ries L, Cancer 2000;88:2398

Risk Appropriate Screening Provider Endorsement/Education Public Acceptance Cost/Efficiency Help Physicians

Risk Appropriate Screening Provider Endorsement/Education Public Acceptance Cost/Efficiency Help Physicians

Sigmoidoscopy Use in 1 o Care Physicians in Allegheny County Surveyed 400 physicians - 70% response rate Median age 44; most full time clinicians Training:44% rigid; 28% flexible Proficiency:32% rigid; 22% flexible Schoen RE, Weissfeld JL, Kuller LH; Preventive Medicine % equipment available Regularly refers or schedules pts: 34% Of those: 50%  5 pts/month

Sigmoidoscopy Use in 1 o Care Physicians in Allegheny County - Attitudes 83% sigmoidoscopy impt 88% agree with ACS rec’s Factors that influence decision to recommend: Cost - 62% Low prob finding a lesion - 52% Patient discomfort - 48%

ACES:Physician Knowledge of Reimbursement for Screening FSG (N=95)

Provider Endorsement Medical services are not baseball stadiums: “Build it and they will come” does NOT Apply

Altering Physician Behavior - CRC Screening Media Effect Liability

Pittsburgh Post-Gazette May 20, 2000

Risk Appropriate Screening Provider Endorsement/Education Public Acceptance Cost/Efficiency Help Physicians

Satisfaction with Flexible Sigmoidoscopy (N=1221) General% Strongly Agree Very Satisfied with care97.6 Pain/Discomfort (Didn’t) have a lot of pain96.2 More comfortable than expected68.5 (Didn’t) cause me great discomfort78.1 Enthusiasm Willing to have another93.1 Sigmoidoscopy will benefit my health91.1 Strongly recommend to friends74.9 Schoen. Arch Intl Med 2000;160:1790

Risk Appropriate Screening Provider Endorsement/Education Public Acceptance Cost/Efficient Delivery Help Physicians

NP’s and Sigmoidoscopy Back to Back FSG, N = 249 Per Polyp Missed Adenomas Missed Adenomas  1 cm Per Patient No polyp FS #1, Polyp FS #2 No adenoma FS #1, Adenoma FS #2 GI 20% (6/30) 2/10 21% (3/14) 0/4.91 NPP Schoenfeld. Gastro 1999;117:312 12% 3% 6% 2%.12.43

10,164 Available T3 Visit 1,360 Did not complete T3 FSG 8,804 (86.4%) Completed T3 FSG Adherence with T3 Flexible Sigmoidoscopy 688 Had T3 Visit 672 No T3 Visit Weissfeld. Cancer 2002 (in press)

Sigmoidoscopy & Mammography Need training for proficiency Need Consistent Experience to Maintain Proficiency Need Current Technology Infection Control High Through-Put Standardize Reporting/Terminology Follow outcome

Risk Appropriate Screening Provider Endorsement/Education Public Acceptance Cost/Efficiency Help Physicians

Systems Approach to Prevention GAPS Put Prevention Into Practice (AHRQ) G oal setting regarding preventive care A ssessment of existing routines P lanning to modify existing routines S tarting and maintaining improved preventive care system Deitrich. Arch Family Med 1994;3:126 PPP

Goals Help physicians assess risk Help physicians recommend action Create visible, high quality, high volume, efficient delivery Affordable Accessible